Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpoint.
Kubica J, Adamski P, Paciorek P, Ładny JR, Kalarus Z, Banasiak W, Kochman W, Gorący J, Wożakowska-Kapłon B, Navarese EP, Kleinrok A, Gil R, Lesiak M, Drożdż J, Kubica A, Filipiak KJ, Kaźmierczak J, Goch A, Grajek S, Basiński A, Szarpak Ł, Grześk G, Hoffman P, Wojakowski W, Gąsior Z, Dobrzycki S, Siller-Matula JM, Witkowski A, Kuliczkowski W, Gruchała M, Timler D, Opolski G, Dudek D, Legutko J, Zielińska M, Wójcik J. Kubica J, et al. Among authors: dobrzycki s. Cardiol J. 2018;25(3):291-300. doi: 10.5603/CJ.a2018.0042. Epub 2018 Apr 19. Cardiol J. 2018. PMID: 29671864 Free article. Review.
Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study.
Kochman W, Dobrzycki S, Nowak KS, Chlopicki S, Kralisz P, Prokopczuk P, Bachorzewska-Gajewska H, Gugala K, Niewada M, Mezynski G, Poniatowski B, Korecki J, Musial WJ. Kochman W, et al. Among authors: dobrzycki s. J Thromb Thrombolysis. 2004 Apr;17(2):127-31. doi: 10.1023/B:THRO.0000037668.89547.a6. J Thromb Thrombolysis. 2004. PMID: 15306748
Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ. Dobrzycki S, et al. Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1. Kardiol Pol. 2006. PMID: 16981054 Clinical Trial.
Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Kochman W, Korecki J, Poniatowski B, Zuk J, Sitniewska E, Bachorzewska-Gajewska H, Sienkiewicz J, Musial WJ. Dobrzycki S, et al. Eur Heart J. 2007 Oct;28(20):2438-48. doi: 10.1093/eurheartj/ehm369. Epub 2007 Sep 20. Eur Heart J. 2007. PMID: 17884846 Clinical Trial.
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.
Witkowski A, Maciejewski P, Wasek W, Malek LA, Niewada M, Kaminski B, Drzewiecki J, Kosmider M, Kubica J, Ruzyllo W, Peruga JZ, Dudek D, Opolski G, Dobrzycki S, Gil RJ; STEMI 2003 Registry Collaborators. Witkowski A, et al. Among authors: dobrzycki s. Eur Heart J. 2009 Jul;30(14):1736-43. doi: 10.1093/eurheartj/ehp114. Epub 2009 Apr 17. Eur Heart J. 2009. PMID: 19376786
244 results